搜索优化
Rewards
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
过去 24 小时
时间不限
过去 1 小时
过去 7 天
过去 30 天
按相关度排序
按时间排序
17 小时
Neumora Therapeutics: A Story Of A Class II Biotech
Neumora's lead asset, Navacaprant, shows weak efficacy in phase 2 trial. Read why we are not optimistic about NMRA's ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
今日热点
One Direction singer dies
Gets minimum 28 years
Campaign denies plagiarism
US Navy aircraft crashes
Exotic cat caught in suburb
Revives Fox News lawsuit
US adults loneliness survey
Had benign cyst removed
Felon voting rights upheld
To return to Atlanta in 2028
Ownership stake approved
Parents sue MA school
$1.4B renovation deal OK'd
$750M US chips grant
'Click to cancel' finalized
MI shooter drill settlement
Cereal dyes protested
Out of disaster loan money
To headline Atlanta rally
Must face US state lawsuits
PA gun restrictions ruling
SpaceX sues CA regulators
Salton Sea conservation
Disney to debut new pass
Ordered to pay $15 million
To invest in nuclear reactors
Broadband data caps probe
New cervical cancer regimen
反馈